Cervical cancer is the second most common cancer in women worldwide and the seventh
most common cause of cancer deaths in women in Europe. Today, we know how to prevent …

Despite the morbidity associated with anogenital condylomas and the mortality associated
with anal, penile, and cervical carcinoma as a direct consequence of human papillomavirus (…

… detection and measurement of human papillomavirus (HPV) infection by amplified and
nonamplified DNA hybridization techniques. The advances in laboratory testing for HPV have …

Background: New screening technologies and vaccination against human papillomavirus (HPV),
the necessary cause of cervical cancer, may impact optimal approaches to prevent …

Background: Human papillomavirus (HPV)-based screening is rapidly replacing cytology as
the cervical screening modality of choice. In addition to being more sensitive than cytology, …

We explored the potential impact of human papillomavirus (HPV) testing on women's intentions
to be screened for cervical cancer in a cohort of Canadian women. Participants aged 25–…

Objectives Given the recent debate challenging the contribution of cytology in cervical
screening, we evaluated results of liquid-based cytology (LBC) and human papillomavirus (HPV) …

… dyskaryotic smear samples were tested for human papillomavirus. After HPV testing in the
pilot … testing, to assess the possible reassuring effects of receiving an HPV negative test result. …

… Negative human papillomavirus testing in normal smears … : the role of human papillomavirus
testing and age at conisation… Human papillomavirus testing following loop electrosurgical …

In the 1920s, when George Papanicolaou began to develop the screening test that now
bears his name, the cause of cervical cancer was not known, and the cancer was a common …